https://www.selleckchem.com/pr....oducts/paeoniflorin.
Nitazoxanide is widely available and exerts broad-spectrum antiviral activity in vitro However, there is no evidence of its impact on SARS-CoV-2 infection.In a multicenter, randomised, double-blind, placebo-controlled trial, adult patients presenting up to 3 days after onset of Covid-19 symptoms (dry cough, fever, and/or fatigue) were enrolled. After confirmation of SARS-CoV2 infection by RT-PCR on a nasopharyngeal swab, patients were randomised 11 to receive either nitazoxanide (500 mg) or placebo, TID, for 5 days. The primary out
Me gusta
Comentario
Compartir
